Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Balch

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
European Journal of Immunology|July 1, 1984
Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adultsT Abo, C A Miller, C M Balch
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patientsK Itoh, N R Pellis, C M Balch
Cancer Research|July 1, 1985
Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cellsK Itoh, A B Tilden, C M Balch
Cellular Immunology|September 1, 1987
Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cellsK Itoh, C D Platsoucas, C M Balch
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibodyA B Tilden, T Abo, C M Balch
The Journal of Experimental Medicine|January 1, 1982
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibodyT Abo, M D Cooper, C M Balch
Cellular Immunology|September 1, 1987
Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activityK Itoh, C M Balch, C D Platsoucas
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Human lymphokine-activated killer (LAK) cells: identification of two types of effector cellsA B Tilden, K Itoh, C M Balch
Seminars in Surgical Oncology|May 1, 1993
Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanomaM I Ross, D Reintgen, C M Balch
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1989
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastasesA Calabro, S E Singletary, C M Balch
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
European Journal of Immunology|July 1, 1984
Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adultsT Abo, C A Miller, C M Balch
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patientsK Itoh, N R Pellis, C M Balch
Cancer Research|July 1, 1985
Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cellsK Itoh, A B Tilden, C M Balch
Cellular Immunology|September 1, 1987
Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cellsK Itoh, C D Platsoucas, C M Balch
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibodyA B Tilden, T Abo, C M Balch
The Journal of Experimental Medicine|January 1, 1982
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibodyT Abo, M D Cooper, C M Balch
Cellular Immunology|September 1, 1987
Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activityK Itoh, C M Balch, C D Platsoucas
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Human lymphokine-activated killer (LAK) cells: identification of two types of effector cellsA B Tilden, K Itoh, C M Balch
Seminars in Surgical Oncology|May 1, 1993
Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanomaM I Ross, D Reintgen, C M Balch
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1989
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastasesA Calabro, S E Singletary, C M Balch
Pageof 23